Paradigm Biopharmaceuticals Ltd (PAR) — Long-term Investment Intensity
Paradigm Biopharmaceuticals Ltd (PAR) has a Long-term Investment Intensity of 0.1% as of June 2021. Long-term investments of AU$102.62K represent 0.1% of total assets of AU$84.79 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Paradigm Biopharmaceuticals Ltd net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Paradigm Biopharmaceuticals Ltd Long-term Investment Intensity (2020–2021)
This chart shows how Paradigm Biopharmaceuticals Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2020 to 2021. As of June 2021, the intensity stands at 0.1%, reflecting long-term investments of AU$102.62K against total assets of AU$84.79 Million AUD. Also explore PAR total asset value for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Paradigm Biopharmaceuticals Ltd (2020–2021)
The table below presents the year-by-year Long-term Investment Intensity for Paradigm Biopharmaceuticals Ltd from 2020 to 2021, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Paradigm Biopharmaceuticals Ltd.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.1% | AU$102.62K | AU$84.79 Million | ▲ +0.0 pp |
| 2020 | 0.1% | AU$102.62K | AU$112.36 Million | — |